GC Therapeutics (Series A)
Funding Details
Awarder
Gaingels
Date Award
May 24, 2024
Vertical
Healthcare and Biotech
Valuation
$146,758,644
Company Info
Founders
Parastoo Kohshakhlagh
Market
Healthcare & Wellness
Coinvestors
Mubadala Capital,Cormorant,AH Bio Fund
Company Description

A biotech company using synthetic biology to program stem cells into any cell type, purportedly with best-in-class efficiency, speed, and scalability; they dictate cells fates in a single step and have validated cells for many applications. GC Therapeutics uses synthetic biology to efficiently, quickly, and scalablely program patient-derived stem cells into any cell type.